Head-to-head
CoreAge Rx vs Spry
CoreAge Rx and Spry both offer GLP-1 telehealth, but they make different trade-offs on speed to first dose, flat pricing, access and molecule choice. Here they are side-by-side on the Rx-Readiness Score — our readiness rubric.
CoreAge Rx
Higher scoreRanked #1 · Grade A
Best for: Working moms who want a decision, not a research project — flat pricing, both semaglutide and tirzepatide, and no scheduled video visit to book around work and pickup.
Visit CoreAge RxSpry
Ranked #31 · Grade C
Best for: A working mom who wants a fast, fully-online start and named founders behind the brand, and will read the 'FDA Approved' badge skeptically rather than at face value.
Visit SpryThe verdict
CoreAge Rx edges out Spry on the Rx-Readiness Score, 95 to 69 (A vs C). Working moms who want a decision, not a research project — flat pricing, both semaglutide and tirzepatide, and no scheduled video visit to book around work and pickup.
Spry is still a genuine option — $199/mo semaglutide, $299/mo tirzepatide, three named co-founders, no contracts, a claimed ~24-hour NP review, and no live video visit described anywhere in the flow — undercut by an on-site 'FDA Approved' badge that overstates what's actually true about compounded GLP-1s, plus no pharmacy named and no state list disclosed. That combination — real speed and a named founding team, next to an overstated regulatory badge and thin disclosure elsewhere — is why Spry lands in the middle of the pack rather than near the top on this site's Rx-Readiness scorecard. Weigh the six readiness factors below against your own priorities.
Side-by-side on the six factors
Both providers scored on the same readiness rubric — the higher side on each factor is marked. See the methodology.
Price, access & features
| Detail | CoreAge Rx | Spry |
|---|---|---|
| Rx-Readiness Score | 95/100 · A | 69/100 · C |
| Overall rank | #1 | #31 |
| Semaglutide | $99/mo | $199/mo |
| Tirzepatide | $149/mo | $299/mo |
| Coverage | All 50 states | Not disclosed |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
CoreAge Rx
Ranked #1 · Grade A
What we like
- Flat monthly price that stays put through titration — no dose-scaling surprise on your busiest month
- Both compounded semaglutide and tirzepatide on one plan, so you're not re-signing to switch
- Async, no-video intake and all-50-states coverage — start it during a lunch break
The caveats
- Not the rock-bottom sticker price — a couple of teaser tiers elsewhere start lower
- Compounded only — no FDA-approved brand option
- General metabolic program, not a boutique concierge service
Spry
Ranked #31 · Grade C
What we like
- Claimed ~24-hour NP review with no live video visit described in the flow
- Three named co-founders — more personal accountability than most compounded-GLP-1 storefronts
- No contracts required
The caveats
- Displays an 'FDA Approved' badge over compounded medications that are not themselves FDA-approved finished products
- No pharmacy named, and no state-availability list found
- Site is a client-rendered app, which made its own pricing harder to verify than a normal marketing page
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Rx-Readiness Score. Pricing, states and verification reflect each provider's public disclosures at last review; the Rx-Readiness Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.
More head-to-heads
Keep comparing CoreAge Rx and Spry against other providers on our shortlist.
Or browse the full comparison hub.